Ftse Mib
33.645,43
-0,27%
DAX
18.001,60
0,54%
S&P 500
5.124,92
1,20%
NASDAQ
16.137,83
1,87%
Bitcoin
61.927,43
4,75%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX NovaBay Pharmaceuticals Inc New (NBY) NovaBay Pharmaceuticals Inc New (NBY) Notizie

NovaBay Pharmaceuticals Inc New

NBY
0,0939
0,0039 (4,33%)
Ultimo aggiornamento: 18:20:26
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/5/202412:50BWNovaBay Pharmaceuticals to Hold 2024 First Quarter..
22/4/202412:57BWNovaBay Pharmaceuticals Announces New and Enhanced..
20/4/202400:00BWNovaBay Pharmaceuticals Receives a NYSE American Notice..
17/4/202412:59BWNovaBay Pharmaceuticals Reports Preliminary Eyecare and..
26/3/202421:05BWNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full..
25/3/202423:38BWNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full..
14/3/202413:00BWNovaBay Pharmaceuticals Announces Agreement to Sell its..
14/2/202420:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202417:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202415:00BWNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in..
10/1/202414:00EDGAR2Form 8-K - Current report
09/1/202415:15BWNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to..
04/1/202417:50EDGAR2Form D - Notice of Exempt Offering of Securities
21/12/202313:58EDGAR2Form 8-K - Current report
11/12/202322:32EDGAR2Form 8-K - Current report
06/12/202312:50BWNovaBay Pharmaceuticals Partners with Woo University to..
09/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:05BWNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202311:50BWNovaBay Pharmaceuticals to Hold Third Quarter 2023..
11/10/202314:00BWNovaBay Pharmaceuticals Expands Physician Dispensed Sales..
02/10/202312:50BWNovaBay Pharmaceuticals to Present at the Dawson James Small..
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
14/9/202314:00BWNovaBay Pharmaceuticals Announces Commercial Launch of..
11/9/202314:00BWNovaBay Pharmaceuticals Announces Agreement with BioStem..
10/8/202322:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:05BWNovaBay Pharmaceuticals Reports Second Quarter 2023..
08/8/202322:05BWNovaBay Pharmaceuticals to Hold Second Quarter 2023..
14/7/202314:30BWNovaBay Pharmaceuticals Reports Record Avenova Sales Day
10/7/202312:50BWNovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day..
07/7/202323:00EDGAR2Form 8-K - Current report
06/7/202323:00EDGAR2Form 8-K - Current report
28/6/202312:50BWNovaBay Pharmaceuticals Supports National Dry Eye Awareness..
20/6/202312:50BWNovaBay Pharmaceuticals to Showcase its Full Line of Avenova..
12/6/202312:50BWNovaBay Pharmaceuticals Announces DERMAdoctor’s KP Duty..
11/5/202322:05BWNovaBay Pharmaceuticals Reports First Quarter 2023 Financial..
05/5/202312:50BWPhaseOne Health Collaborates with Nonprofit Humanitarian..
04/5/202312:50BWNovaBay Pharmaceuticals to Hold First Quarter 2023..
Apertura: 0,0915 Min: 0,09 Max: 0,10
Chiusura: 0,09

La tua Cronologia

AMEX
NBY
NovaBay Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network